Clinical Technologies

INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

Quantifying Potential: Leveraging Data To Showcase Biotech Value
Biotechs must use data-driven insights to prove asset potential. Real-world evidence and predictive analytics validate differentiation, forecast market opportunity, and build investor confidence.
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
Harnessing The Potential Of Patient-Level Data In Clinical Trials  
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
CRO Takes Trial Build Times From Weeks To Days
Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.

Deciphering The FDA's Diversity Plan Updated Guidance
7/16/2024

Updated FDA guidance from June outlines the format and content of Diversity Action Plans, the products and studies requiring a plan, and the submission process. Learn about the changes and what to expect.
The New Standard In Participant-Centric Trials
8/21/2025

Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
The Promise And Peril Of AI In Clinical Trials
7/16/2024

In clinical research, as with many industries, AI is met with both excitement and trepidation. The impact of AI and machine learning is starting to be felt across the pharmaceutical industry.
How Sponsors Can Drive Success With Central eSource At Investigator Sites
6/17/2025

Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.
Unlock Efficiency And Compliance With Data Modernization Solutions
10/29/2025

Designed for leaders and professionals in the life sciences sector, this piece provides a practical framework for transforming data management into a catalyst for efficiency, compliance, and long-term innovation.

IQVIA Feasibility

Employing a digital, data-first strategy, IQVIA Feasibility brings together survey data, confidential disclosure agreements (CDAs) and site intelligence data, enabling sponsors to efficiently collect vital information while improving the site experience.
Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle

Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
End-To-End Safety Solutions Designed For Success

As one of the world’s largest and most experienced safety and PV organizations, unearth how this provider is bringing extensive expertise and regulatory intelligence to every industry engagement.
De-Risk Randomization With The Endpoint Biostatistical Approach

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
Patient-Centric, Native App Helps To Streamline TrialsPatient-Centric, Native App Helps To Streamline Trials

The myMedidata App is a patient-centric, native app designed to provide trial participants with another option for a seamless platform experience and single login for all of their remote trial activities.